胃肠道疼痛的中心介导性疾病
Shin Fukudo1, Qasim Aziz2, Douglas A Drossman3
1Tohoku University Graduate School of Medicine, Research Center for Accelerator and Radioisotope Science, Tohoku University, Sendai, Japanese Red Cross Ishinomaki Hospital, Ishinomaki, Japan.
Gastroenterology
|February 15, 2026
概括
这项研究详细介绍了胃肠道疼痛的三个中心疾病:中心介导的腹部疼痛综合征,腹部偏头痛和阿片类药物诱导的胃肠道过敏症. 有效的管理包括药物治疗,行为治疗和强大的医生与患者关系.
科学领域:
- 胃肠病学 胃肠病学
- 神经科学是一个神经科学.
- 疼痛医学 医学 疼痛医学
背景情况:
- 越来越多地认识到中央介导的胃肠道疼痛障碍.
- 这些情况涉及中枢神经系统内脏疼痛信号的处理变化.
研究的目的:
- 确定和描述三个中央介导的胃肠道疼痛障碍.
- 概述它们的流行病学,病理生理学,临床评估和治疗选择.
主要方法:
- 对集中介导的腹痛综合征,腹部偏头痛和麻醉性肠综合征/阿片类药物诱导的胃肠过敏症现有文献的综述.
- 综合有关病理生理学,临床表现和治疗策略的信息.
主要成果:
- 集中介导腹痛综合征呈现为慢性疼痛,与生理事件相关或不相关,由中央敏感化驱动.
- 腹部偏头痛的特点是成年人经常出现重复的,刻板印象的剧烈腹部疼痛.
- 麻醉性肠综合征/阿片类药物诱导的胃肠道过敏症涉及阿片类药物使用的矛盾疼痛增加.
结论:
- 有效的管理需要一种多模式的方法,包括药物治疗,脑肠行为疗法和神经调节.
- 强大的医生与患者关系对于成功的治疗结果至关重要.
- 了解中央敏感性是解决这些复杂疼痛障碍的关键.
相关概念视频
Other Disorders of Digestive System
1.5K
The gastrointestinal tract is susceptible to various disorders. If the lower esophageal sphincter is damaged, stomach acid can flow back into the esophagus, causing irritation and inflammation of the lining. This condition is called gastroesophageal reflux disease (known as heartburn) and may cause chest pain and difficulty swallowing. In the stomach, prolonged use of nonsteroidal anti-inflammatory drugs like aspirin, chronic alcohol consumption, bacterial infections such as Helicobacter...
1.5K
Irritable Bowel Syndrome I: Introduction
1.2K
Irritable Bowel Syndrome (IBS) is characterized by functional disturbances in the gastrointestinal system, presenting a cluster of symptoms without evident structural or biochemical abnormalities. It primarily affects the large intestine and may cause abdominal pain, bloating, excessive gas, diarrhea, constipation, or both.
IBS is a chronic condition that can persist over a long period or recur frequently.
The pathogenesis of IBS involves a complex interplay of the following factors:
Altered...
IBS is a chronic condition that can persist over a long period or recur frequently.
The pathogenesis of IBS involves a complex interplay of the following factors:
Altered...
1.2K
Gastrointestinal Motility Disorders
1.3K
Gastrointestinal or GI motility disorders are characterized by irregular gastrointestinal tract movements, disrupting food transit from the mouth to the anus. They are caused by damage or dysfunction in gut muscles or nerves. These disorders can cause symptoms such as severe constipation, diarrhea, abdominal pain, and swallowing difficulties. Disorders can affect any segment of the GI tract and range widely in severity, from common conditions like GERD to life-threatening conditions like...
1.3K
Chronic Bowel Disorders: Introduction
817
Chronic bowel diseases are a group of long-term conditions affecting the digestive tract, characterized by inflammation and damage to the gut lining. These conditions primarily include irritable bowel syndrome and inflammatory bowel disease.
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
817
Drugs for Treatment of Diarrhea-Predominant IBS
754
Diarrhea-predominant irritable bowel syndrome (IBS-D) is a subtype of IBS characterized primarily by frequent, loose, or watery stools, abdominal pain, and abdominal discomfort. Therapeutic approaches to managing IBS-D include dietary changes, stress management techniques, and pharmaceutical interventions.
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
754
Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies
649
Peptic ulcer disease (PUD) presents with diverse symptoms depending on the location and severity of the ulcer. Clinical manifestations of peptic ulcer include dull pain and a burning sensation in the mid-epigastric region.
Few clinical manifestations differentiate gastric ulcers from duodenal ulcers. Distinctions in the location, timing, and pain relief are crucial for healthcare providers in differentiating between gastric and duodenal ulcers during clinical assessments.
Few clinical manifestations differentiate gastric ulcers from duodenal ulcers. Distinctions in the location, timing, and pain relief are crucial for healthcare providers in differentiating between gastric and duodenal ulcers during clinical assessments.
649


